Telehealth Support for Caregivers of Cancer Patients

This study is looking at whether a telehealth (virtual healthcare) support program can help caregivers of patients undergoing a specific cancer surgery called CS+HIPEC (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy). We know that these caregivers often face significant stress, depression, and financial difficulties. This study aims to see if providing resources and support through telehealth can reduce these burdens, improve their quality of life, and help them feel more capable in their caregiving role. We are measuring how many caregivers complete a depression scale to see if this approach is practical. You may be able to join if you are the primary caregiver for a patient receiving CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center, are 18 or older, have access to a computer or smartphone, and can read and write English.

Study design
This interventional study plans to enroll 50 participants. Participants will be randomly assigned to either receive a telehealth navigation intervention or standard caregiving experience.
What's involved
Participants in the intervention group will receive a telehealth navigation intervention, which may include referrals to specific resources, lasting over 1 hour, 1-4 weeks before the patient's surgery.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, a depression scale, will be measured at 1 and 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06709404

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Recruiting
NAAges 18+InterventionalSupportive care
Wake Forest University Health Sciences
~50 participants
Updated 2026-04-13 on ClinicalTrials.gov
What's tested:TelemedicineSurvey administrationElectronic health record reviewBest Practice

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Caregivers to Complete Center for Epidemiologic Studies-Depression Scale (CES-D) - (Feasibility)
Measured over At 1 and 2 years
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

NCT06709404

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Wake Forest Baptist Comprehensive Cancer Center

    Winston-Salem, North Carolinano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Katie Duckworth · PRINCIPAL_INVESTIGATOR · Wake Forest Baptist Comprehensive Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Primary caregiver of a patient scheduled to receive CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Access to a computer or smartphone and must have an email address
18 years of age or older at the time of consent
The ability to understand and willingness to provide written informed consent
The ability to read and write English
  • Number of Caregivers to Complete Center for Epidemiologic Studies-Depression Scale (CES-D) - (Feasibility)At 1 and 2 years

    Feasibility will be measured by the number of caregivers who complete the Center for Epidemiologic Studies-Depression Scale (CES-D). The 95% confidence interval for the observed rates will be calculated.